Immunotherapy empowers the immune system to attack diseased cells. See how researchers harness this power.
Do Tumors Hold the Key to Their Own Destruction?
By studying the interactions between a tumor and a patient's immune system, researchers at biopharmaceutical companies such as Bristol-Myers Squibb (BMS) are trying to reduce the ambiguity involved in fighting cancer.READ MORE
More Than 240 Immuno-oncology Treatments in Development to Fight Cancer
The need for new cancer treatments is more important than ever, and America's biopharmaceutical companies are boldly leading the way in discovering new breakthroughs.READ MORE